This is good news for the coronavirus vaccine! India’s Drugs Controller General of India (DGCI) drug regulator has approved Oxford’s COVID-19 vaccine Covishield and Bharat Biotech’s Covaxin for restricted emergency use in a major development.

The major development took place after the press conference of the Drug Controller General of India (DGCI).

It’s a big good news in terms of coronavirus vaccine! In a major development, India’s drugs regulator Drugs Controller General of India (DGCI) has approved Oxford’s COVID-19 vaccine Covishield and Bharat Biotech’s Covaxin for restricted emergency use.

The big development took place after Press Conference by Drugs Controller General of India (DGCI).

Meanwhile, India’s COVID-19 tally of cases climbed to 1,03,23,965 with 18,177 new cases in a day, while 99,27,310 people have recuperated so far pushing the national recovery rate to 96.15 per cent on Sunday, according to the Union Health Ministry data.